1)  Lymphotoxin
淋巴毒
2)  Lymphotoxin
淋巴毒素
1.
Clinical Pharmacokinetic Trial of Intravenous Injection of Recombinant Human Lymphotoxin-α Derivative;
注射用重组人淋巴毒素α衍生物的临床药代动力学研究
2.
Phase Ⅰ Clinical Trial of Intravenous Recombinant Human Lymphotoxin-α Derivative;
注射用重组人淋巴毒素α衍生物Ⅰ期临床耐受性研究
3.
Construction of Combined Site-directed Random Mutation Libraries of Recombinant Human Lymphotoxin;
重组人淋巴毒素随机点突变组合文库的构建
3)  Lymphotoxin-α
淋巴毒素-α
4)  lymphocytotoxic crossmatch
淋巴毒试验
1.
Methods:Among 1 152 cases,550 cases received anti donor lymphocytotoxic crossmatch(LXM),335 cases received LXM and HLA serological test,267 cases of the latter again received panel reaction antibody(PRA)test, the change of the HAR rate with different HLA matching measures were analyzed.
方法 :115 2例肾移植中有 5 5 0例单纯行淋巴细胞毒抗体试验 (简称淋巴毒 ) ,335例行淋巴毒试验和 HL A血清学分型 ,在此基础上有 2 6 7例增加 PRA检测 ,观察每组超排发生率的变化。
5)  Lymphotoxinα
淋巴毒素α
1.
Objective:To identify polymorphism of lymphotoxinα(LT-α),and to determine whether lymphotoxinα(LT-α)NcoI gene polymorphism is associated with genetic predisposition of coronary heart disease in Chinese Han population.
目的:检测淋巴毒素α(LT-α)NcoⅠ基因多态性,并探讨其与我国汉族冠心病(CHD)遗传易感性之间的关系。
6)  Microlymphocytotoxicity
微量淋巴毒
1.
Significance and detection of expression on HLA-B27 antigen by flow cytometry:comparison of microlymphocytotoxicity test;
流式细胞术检测HLA-B27抗原的表达及意义——与微量淋巴毒实验的比较
参考词条
补充资料：淋巴毒素
分子式：
CAS号：

性质：见肿瘤坏死因子 

说明：补充资料仅用于学习参考，请勿用于其它任何用途。